Plasma Metabolites as Predictors of Warfarin Outcome in Atrial Fibrillation

Conclusions and ImplicationsWe have shown that the pharmacometabonomics technique was able to differentiate between unstable and stable INR with good accuracy. NMR-based pharmacometabonomics has the potential to identify novel biomarkers in plasma, which can be useful in individualizing treatment and controlling warfarin side effects, thus, minimizing undesirable effects in the future.
Source: American Journal of Cardiovascular Drugs - Category: Cardiology Source Type: research